We have evaluated the therapeutic and biological effects of BI 853520, a novel, potent, and selective small chemical entity kinase FAK-I24, in cultured murine breast cancer cells in vitro and in various transplantation and transgenic mouse models of breast cancer in vivo. The gene discussed is PTK2; the disease is breast cancer.